Siemens Healthineers stock gains 3.28 percent as Q3 profit rises

Siemens Healthineers stock (ISIN DE000SHL1006) was trading at EUR 39.03 on Xetra on September 28, 2026, up 3.28 percent from the previous close of EUR 37.79. The latest fiscal quarter delivered a sharper earnings increase than revenue growth, giving the market a concrete profitability signal.

Q3 profit outpaces revenue growth

For the fiscal third quarter ended June 30, 2026, revenue reached EUR 5.764 billion, up 1.80 percent from EUR 5.662 billion a year earlier, according to VCBeat. The same period produced adjusted EBIT of EUR 1.101 billion, an increase of 15.60 percent from EUR 953 million.

Net profit rose to EUR 676 million from EUR 556 million in the prior-year quarter, a 21.70 percent increase, VCBeat reported. The gap between 1.80 percent revenue growth and 21.70 percent net-profit growth makes earnings conversion the central reading of the update.

Analyst targets remain above the quote

Jefferies maintained a Buy rating and a EUR 50.00 price target on September 4, 2026, according to MarketScreener. Against the EUR 39.03 Xetra price, that target is 28.18 percent higher.

Market data put Siemens Healthineers market capitalization at EUR 43.7 billion on September 28, 2026. The stock's 52-week range was EUR 32.81 to EUR 49.71, placing the current quote EUR 10.68 below the yearly high and EUR 6.22 above the low.

Stock trades above EUR 39

Siemens Healthineers was last quoted at EUR 39.03 on Xetra at 12:24 p.m. CEST on September 28, 2026, with 235,513 shares traded. For investors, the key contrast is clear: the share price remains below its 52-week high, while fiscal Q3 net profit grew 21.70 percent year over year.

More news and analyses on Siemens Healthineers stock